Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-12

Clinical Trial Update: Enhancement of Macular Pigment Density by Oral Lutein Supplementation [NA]

View source ↗

Summary

A completed clinical trial evaluating whether oral lutein supplementation can enhance macular pigment density in age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lutein supplement (lutein)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Age-Related Maculopathies | NA | Status: COMPLETED